Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q34186242)
Watch
English
Novel melatonin-based therapies: potential advances in the treatment of major depression
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
21596429
retrieved
31 July 2017
review article
1 reference
stated in
Europe PubMed Central
title
Novel melatonin-based therapies: potential advances in the treatment of major depression
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
21596429
retrieved
31 July 2017
main subject
melatonin
0 references
author
Naomi L Rogers
object named as
Naomi L Rogers
series ordinal
2
0 references
author name string
Ian B Hickie
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
21596429
retrieved
31 July 2017
language of work or name
English
0 references
publication date
17 May 2011
1 reference
stated in
Europe PubMed Central
PubMed ID
21596429
retrieved
31 July 2017
published in
The Lancet
1 reference
stated in
Europe PubMed Central
PubMed ID
21596429
retrieved
31 July 2017
volume
378
1 reference
stated in
Europe PubMed Central
PubMed ID
21596429
retrieved
31 July 2017
issue
9791
1 reference
stated in
Europe PubMed Central
PubMed ID
21596429
retrieved
31 July 2017
page(s)
621-631
1 reference
stated in
Europe PubMed Central
PubMed ID
21596429
retrieved
31 July 2017
cites work
Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Is depression overdiagnosed? No.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Association between antidepressant prescribing and suicide in Australia, 1991-2000: trend analysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The circadian basis of mood disorders: recent developments and treatment implications
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Circadian rhythm disturbances in depression
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Interaction of chronic sleep restriction and circadian system in humans
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Circadian genes and bipolar disorder
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
New insights into the mammalian circadian clock.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Entrainment of the human circadian system by light
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Circadian rhythms in depression and recovery: evidence for blunted amplitude as the main chronobiological abnormality.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hypersomnia across mood disorders: a review and synthesis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Sleep complaints and depression in an aging cohort: A prospective perspective
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Contribution of the circadian pacemaker and the sleep homeostat to sleep propensity, sleep structure, electroencephalographic slow waves, and sleep spindle activity in humans.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Circadian genes, rhythms and the biology of mood disorders
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Three circadian clock genes Per2, Arntl, and Npas2 contribute to winter depression
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Sleep and circadian rhythm disruption in psychiatric and neurodegenerative disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Association study of 21 circadian genes with bipolar I disorder, schizoaffective disorder, and schizophrenia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Interpersonal and social rhythm therapy: a means of improving depression and preventing relapse in bipolar disorder.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Drug effects on REM sleep and on endogenous depression
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Biomarkers for the effects of selective serotonin reuptake inhibitors (SSRIs) in healthy subjects
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Promoting adjustment of the sleep-wake cycle by chronobiotics
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
From the basic neuroscience of circadian clock function to light therapy for depression: on the emergence of chronotherapeutics
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
High sensitivity of the human circadian melatonin rhythm to resetting by short wavelength light
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Rapid and sustained antidepressant response with sleep deprivation and chronotherapy in bipolar disorder
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Melatonin and Melatonin Analogues
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Rhythms and the pharmacology of lithium
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of Lithium Carbonate on Circadian Periodicity in Humans
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Molecular effects of lithium
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A role for glycogen synthase kinase-3beta in the mammalian circadian clock
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Chronotherapeutics (light and wake therapy) in affective disorders
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Patterns of performance degradation and restoration during sleep restriction and subsequent recovery: a sleep dose-response study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The cumulative cost of additional wakefulness: dose-response effects on neurobehavioral functions and sleep physiology from chronic sleep restriction and total sleep deprivation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Impact of sleep debt on metabolic and endocrine function
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The Efficacy of Light Therapy in the Treatment of Mood Disorders: A Review and Meta-Analysis of the Evidence
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Light therapy for non-seasonal depression
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy of light therapy in nonseasonal depression: a systematic review
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The pattern of melatonin receptor expression in the brain may influence antidepressant treatment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mammalian melatonin receptors: molecular biology and signal transduction.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Negative effects of melatonin on depression
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pathophysiology of depression: role of sleep and the melatonergic system
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The Novel Melatonin Agonist Agomelatine (S20098) Is an Antagonist at 5-Hydroxytryptamine2C Receptors, Blockade of Which Enhances the Activity of Frontocortical Dopaminergic and Adrenergic Pathways
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Chronobiotic effects of the melatonin agonist LY 156735 following a simulated 9h time shift: results of a placebo-controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy of prolonged release melatonin in insomnia patients aged 55–80 years: quality of sleep and next-day alertness outcomes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The effects of ramelteon in a first-night model of transient insomnia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomnia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A 2-night, 3-period, crossover study of ramelteon's efficacy and safety in older adults with chronic insomnia.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Preclinical pharmacokinetics and metabolism of BMS-214778, a novel melatonin receptor agonist
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Agomelatine, a melatonin agonist with antidepressant properties
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The emerging role of melatonin agonists in the treatment of major depression: focus on agomelatine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Behavioural and neuroplastic effects of the new-generation antidepressant agomelatine compared to fluoxetine in glucocorticoid receptor-impaired mice
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase-shifts of 24-h rhythms of hormonal release and body temperature following early evening administration of the melatonin agonist agomelatine in healthy older men.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Agomelatine: a preliminary review of a new antidepressant
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Agomelatine in the treatment of major depressive disorder: potential for clinical effectiveness
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Determination of the dose of agomelatine, a melatoninergic agonist and selective 5-HT(2C) antagonist, in the treatment of major depressive disorder: a placebo-controlled dose range study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Placebo-controlled trial of agomelatine in the treatment of major depressive disorder
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Agomelatine in the treatment of major depressive disorder: an 8-week, multicenter, randomized, placebo-controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy and safety of agomelatine in the treatment of major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy of the novel antidepressant agomelatine on the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: a randomized, double-blind comparison with sertraline
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Improvement in subjective sleep in major depressive disorder with a novel antidepressant, agomelatine: randomized, double-blind comparison with venlafaxine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A double-blind comparison of sexual functioning, antidepressant efficacy, and tolerability between agomelatine and venlafaxine XR.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Superior antidepressant efficacy results of agomelatine versus fluoxetine in severe MDD patients: a randomized, double-blind study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Absence of discontinuation symptoms with agomelatine and occurrence of discontinuation symptoms with paroxetine: a randomized, double-blind, placebo-controlled discontinuation study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Agomelatine prevents relapse in patients with major depressive disorder without evidence of a discontinuation syndrome: a 24-week randomized, double-blind, placebo-controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Beyond the monoaminergic hypothesis: agomelatine, a new antidepressant with an innovative mechanism of action
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Better sexual acceptability of agomelatine (25 and 50 mg) compared with paroxetine (20 mg) in healthy male volunteers. An 8-week, placebo-controlled study using the PRSEXDQ-SALSEX scale.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The pharmacological properties of antidepressants
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The antidepressant agomelatine improves the quality of life of depressed patients: implications for remission
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960095-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0140-6736(11)60095-0
1 reference
stated in
Europe PubMed Central
PubMed ID
21596429
retrieved
31 July 2017
PubMed ID
21596429
1 reference
stated in
Europe PubMed Central
PubMed ID
21596429
retrieved
31 July 2017
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit